Marco Gottardis

Person

Princeton, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating prostate cancer
- Patent number 11,992,486
- Issue date May 28, 2024
- JANSSEN PHARMACEUTICA NV
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating prostate cancer
- Patent number 11,986,470
- Issue date May 21, 2024
- JANSSEN PHARMACEUTICA NV
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating prostate cancer
- Patent number 11,986,468
- Issue date May 21, 2024
- JANSSEN PHARMACEUTICA NV
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating prostate cancer
- Patent number 11,986,469
- Issue date May 21, 2024
- JANSSEN PHARMACEUTICA NV
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prostate neoantigens and their uses
- Patent number 11,793,843
- Issue date Oct 24, 2023
- Janssen Biotech, Inc.
- Kurtis E. Bachman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating prostate cancer
- Patent number 11,207,311
- Issue date Dec 28, 2021
- JANSSEN PHARMACEUTICA NV
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific EGFR/IGFIR binding molecules
- Patent number 10,954,286
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Stuart Emanuel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating cancer by administering multivalent fibronectin...
- Patent number 10,774,130
- Issue date Sep 15, 2020
- Bristol-Myers Squibb Company
- Ray Camphausen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules
- Patent number 10,183,987
- Issue date Jan 22, 2019
- Bristol-Myers Squibb Company
- Stuart Emanuel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent fibronectin based scaffold domain proteins
- Patent number 9,902,762
- Issue date Feb 27, 2018
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating cancer by administering EGFR and EGFR/IGFIR bind...
- Patent number 9,771,411
- Issue date Sep 26, 2017
- Bristol-Myers Squibb Company
- Stuart Emanuel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific EGFR/IGFIR binding molecules
- Patent number 9,017,655
- Issue date Apr 28, 2015
- Bristol-Myers Squibb Company
- Stuart Emanuel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multivalent fibronectin based scaffold domain proteins
- Patent number 8,728,483
- Issue date May 20, 2014
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarkers and methods for determining sensitivity to insulin growt...
- Patent number 8,492,328
- Issue date Jul 23, 2013
- Bristol-Myers Squibb Company
- Fei Huang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bispecific EGFR/IGFIR binding molecules
- Patent number 8,343,501
- Issue date Jan 1, 2013
- Bristol-Myers Squibb Company
- Stuart Emanuel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent fibronectin based scaffold domain proteins
- Patent number 8,221,765
- Issue date Jul 17, 2012
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused cyclic succinimide compounds and analogs thereof, modulators...
- Patent number 7,655,688
- Issue date Feb 2, 2010
- Bristol-Myers Squibb Company
- Mark E. Salvati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polynucleotides encoding human histone deacetylase HDAC9c
- Patent number 7,199,227
- Issue date Apr 3, 2007
- Bristol-Myers Squibb Company
- Donald G. Jackson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for identifying or screening for agents that modulate 17β-HSD3
- Patent number 7,138,246
- Issue date Nov 21, 2006
- Bristol-Myers Squibb Company
- Matthew V. Lorenzi
- G01 - MEASURING TESTING
Information Patent Grant
Method for the treatment of a condition remediable by administratio...
- Patent number 6,960,474
- Issue date Nov 1, 2005
- Bristol-Myers Squibb Company
- Mark E. Salvati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treatment of hyperproliferative diseases
- Patent number 6,624,154
- Issue date Sep 23, 2003
- Bristol-Myers Squibb Company
- Gérard Benoit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PROSTATE NEOANTIGENS AND THEIR USES
- Publication number 20240139265
- Publication date May 2, 2024
- Jansen Biotech, Inc.
- Kurtis E. Bachman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Prostate Cancer
- Publication number 20240000766
- Publication date Jan 4, 2024
- Janssen Pharmaceutica N.V.
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Prostate Cancer
- Publication number 20230149380
- Publication date May 18, 2023
- Janssen Pharmaceutica N.V.
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Prostate Cancer
- Publication number 20230098047
- Publication date Mar 30, 2023
- Janssen Pharmaceutica N.V.
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Prostate Cancer
- Publication number 20230078160
- Publication date Mar 16, 2023
- Janssen Pharmaceutica N.V.
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Prostate Cancer
- Publication number 20220071980
- Publication date Mar 10, 2022
- Janssen Pharmaceutica N.V.
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Prostate Cancer
- Publication number 20220071979
- Publication date Mar 10, 2022
- Janssen Pharmaceutica N.V.
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA AND STEAP1 VACCINES AND THEIR USES
- Publication number 20210315986
- Publication date Oct 14, 2021
- JANSSEN BIOTECH, INC.
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS
- Publication number 20210017252
- Publication date Jan 21, 2021
- Bristol-Myers Squibb Company
- Ray CAMPHAUSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROSTATE NEOANTIGENS AND THEIR USES
- Publication number 20200222478
- Publication date Jul 16, 2020
- JANSSEN BIOTECH, INC.
- Kurtis E. Bachman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC EGFR/IGFIR BINDING MOLECULES
- Publication number 20190153069
- Publication date May 23, 2019
- Bristol-Myers Squibb Company
- Stuart EMANUEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF TREATING PROSTATE CANCER
- Publication number 20190022079
- Publication date Jan 24, 2019
- Janssen Pharmaceutica N.V.
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS
- Publication number 20180265572
- Publication date Sep 20, 2018
- Bristol-Myers Squibb Company
- Ray CAMPHAUSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC EGFR/IGFIR BINDING MOLECULES
- Publication number 20180037631
- Publication date Feb 8, 2018
- Bristol-Myers Squibb Company
- Stuart EMANUEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of Treating Prostate Cancer
- Publication number 20180028521
- Publication date Feb 1, 2018
- Janssen Pharmaceutica N.V.
- Marco Gottardis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC EGFR/IGFIR BINDING MOLECULES
- Publication number 20150259398
- Publication date Sep 17, 2015
- Bristol-Myers Squibb Company
- Stuart EMANUEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS
- Publication number 20140349929
- Publication date Nov 27, 2014
- Bristol-Myers Squibb Company
- Ray CAMPHAUSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC EGFR/IGFIR BINDING MOLECULES
- Publication number 20130157948
- Publication date Jun 20, 2013
- Bristol-Myers Squibb Company
- Stuart EMANUEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS
- Publication number 20130012435
- Publication date Jan 10, 2013
- Bristol-Myers Squibb Company
- Ray Camphausen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF VEGFR2 AND IGF1R INHIBITORS FOR THE TREATMENT OF PRO...
- Publication number 20110123545
- Publication date May 26, 2011
- Bristol -Myers Squibb Company
- H. Nicholas Marsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO INSULIN GROWT...
- Publication number 20100184125
- Publication date Jul 22, 2010
- Bristol -Myers Squibb Company
- Fei Huang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC EGFR/IGFIR BINDING MOLECULES
- Publication number 20100179094
- Publication date Jul 15, 2010
- Bristol-Myers Squibb Company
- Stuart Emanuel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS
- Publication number 20090299040
- Publication date Dec 3, 2009
- Bristol-Myers Squibb Company
- RAY CAMPHAUSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel human histone deacetylases
- Publication number 20060269559
- Publication date Nov 30, 2006
- Bristol -Myers Squibb Company
- Donald G. Jackson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Fused cyclic succinimide compounds and analogs thereof, modulators...
- Publication number 20060111424
- Publication date May 25, 2006
- Mark E. Salvati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Selective androgen receptor modulators and methods for their identi...
- Publication number 20050256048
- Publication date Nov 17, 2005
- Mark E. Salvati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for identifying or screening for agents that modulate 17bet...
- Publication number 20050191707
- Publication date Sep 1, 2005
- Matthew V. Lorenzi
- G01 - MEASURING TESTING
Information Patent Application
Methods for treating IGF1R-inhibitor induced hyperglycemia
- Publication number 20050075358
- Publication date Apr 7, 2005
- Joan M. Carboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Synergistic methods and compositions for treating cancer
- Publication number 20040209930
- Publication date Oct 21, 2004
- Joan M. Carboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Synergist combinations of retinoid receptor ligands and selected cy...
- Publication number 20040122080
- Publication date Jun 24, 2004
- Valerie S Vivat-Hannah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Marco Gottardis

Person

Patents Grantslast 30 patents

Methods of treating prostate cancer

Methods of treating prostate cancer

Methods of treating prostate cancer

Methods of treating prostate cancer

Prostate neoantigens and their uses

Method of treating prostate cancer

Bispecific EGFR/IGFIR binding molecules

Method of treating cancer by administering multivalent fibronectin...

Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules

Multivalent fibronectin based scaffold domain proteins

Method of treating cancer by administering EGFR and EGFR/IGFIR bind...

Bispecific EGFR/IGFIR binding molecules

Multivalent fibronectin based scaffold domain proteins

Biomarkers and methods for determining sensitivity to insulin growt...

Bispecific EGFR/IGFIR binding molecules

Multivalent fibronectin based scaffold domain proteins

Fused cyclic succinimide compounds and analogs thereof, modulators...

Polynucleotides encoding human histone deacetylase HDAC9c

Methods for identifying or screening for agents that modulate 17β-HSD3

Method for the treatment of a condition remediable by administratio...

Compositions and methods for treatment of hyperproliferative diseases

Patents Applicationslast 30 patents

PROSTATE NEOANTIGENS AND THEIR USES

Methods of Treating Prostate Cancer

Methods of Treating Prostate Cancer

Methods of Treating Prostate Cancer

Methods of Treating Prostate Cancer

Methods of Treating Prostate Cancer

Methods of Treating Prostate Cancer

PSMA AND STEAP1 VACCINES AND THEIR USES

MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS

PROSTATE NEOANTIGENS AND THEIR USES

BISPECIFIC EGFR/IGFIR BINDING MOLECULES

METHOD OF TREATING PROSTATE CANCER

MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS

BISPECIFIC EGFR/IGFIR BINDING MOLECULES

Methods of Treating Prostate Cancer

BISPECIFIC EGFR/IGFIR BINDING MOLECULES

MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS

BISPECIFIC EGFR/IGFIR BINDING MOLECULES

MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS

COMBINATION OF VEGFR2 AND IGF1R INHIBITORS FOR THE TREATMENT OF PRO...

BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO INSULIN GROWT...

BISPECIFIC EGFR/IGFIR BINDING MOLECULES

MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS

Novel human histone deacetylases

Fused cyclic succinimide compounds and analogs thereof, modulators...

Selective androgen receptor modulators and methods for their identi...

Methods for identifying or screening for agents that modulate 17bet...

Methods for treating IGF1R-inhibitor induced hyperglycemia

Synergistic methods and compositions for treating cancer

Synergist combinations of retinoid receptor ligands and selected cy...